BIOVIC B — Biovica International AB Cashflow Statement
0.000.00%
- SEK86.11m
- SEK40.55m
- SEK13.38m
Annual cashflow statement for Biovica International AB, fiscal year end - April 30th, SEK millions except per share, conversion factor applied.
2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | 2026 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -60.1 | -110 | -127 | -85.8 | -70.1 |
| Depreciation | |||||
| Non-Cash Items | 0.052 | 0.007 | 0.367 | -0.291 | 1.09 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.48 | 7.6 | 2.48 | -8.08 | -2.08 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -52.1 | -94.6 | -115 | -85.4 | -62.8 |
| Capital Expenditures | -3.4 | -2.78 | -0.146 | -0.287 | -0.474 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | -0.439 | 0 | — |
| Purchase of Investments | |||||
| Cash from Investing Activities | -3.4 | -2.78 | -0.585 | -0.287 | -0.474 |
| Financing Cash Flow Items | — | -25.2 | -16.7 | 0.001 | -9.95 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.136 | 122 | 79.5 | 30.9 | 109 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -55.6 | 24.5 | -34.9 | -55 | 46 |